ALLR
Price
$1.32
Change
-$0.03 (-2.21%)
Updated
Jun 23, 03:53 PM (EDT)
Capitalization
21.64M
112 days until earnings call
Intraday BUY SELL Signals
CYPH
Price
$0.65
Change
-$0.09 (-12.16%)
Updated
Jun 23, 04:05 PM (EDT)
Capitalization
76.97M
Intraday BUY SELL Signals
Interact to see
Advertisement

ALLR vs CYPH

ALLR vs CYPH Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ALLR vs. CYPH commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLR is a Hold and CYPH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (ALLR: $1.36 vs. CYPH: $0.72)
Brand notoriety: ALLR and CYPH are both not notable
ALLR represents the Biotechnology, while CYPH is part of the Investment Managers industry
Current volume relative to the 65-day Moving Average: ALLR: 67% vs. CYPH: 91%
Market capitalization -- ALLR: $21.64M vs. CYPH: $76.97M
ALLR [@Biotechnology] is valued at $21.64M. CYPH’s [@Investment Managers] market capitalization is $76.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The market cap for tickers in the [@Investment Managers] industry ranges from $163.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2B. The average market capitalization across the [@Investment Managers] industry is $9.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLR’s FA Score shows that 1 FA rating(s) are green whileCYPH’s FA Score has 1 green FA rating(s).

  • ALLR’s FA Score: 1 green, 4 red.
  • CYPH’s FA Score: 1 green, 4 red.
According to our system of comparison, ALLR is a better buy in the long-term than CYPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLR’s TA Score shows that 3 TA indicator(s) are bullish while CYPH’s TA Score has 6 bullish TA indicator(s).

  • ALLR’s TA Score: 3 bullish, 5 bearish.
  • CYPH’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CYPH is a better buy in the short-term than ALLR.

Price Growth

ALLR (@Biotechnology) experienced а -8.11% price change this week, while CYPH (@Investment Managers) price change was -11.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

The average weekly price growth across all stocks in the @Investment Managers industry was -2.28%. For the same industry, the average monthly price growth was -2.46%, and the average quarterly price growth was -8.13%.

Reported Earning Dates

ALLR is expected to report earnings on Oct 13, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Investment Managers (-2.28% weekly)

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYPH($77M) has a higher market cap than ALLR($21.6M). CYPH has higher P/E ratio than ALLR: CYPH (17.07) vs ALLR (0.12). ALLR YTD gains are higher at: 25.926 vs. CYPH (-37.672). ALLR has higher annual earnings (EBITDA): -10.89M vs. CYPH (-56.75M). ALLR has more cash in the bank: 19.8M vs. CYPH (6.69M). CYPH has less debt than ALLR: CYPH (38K) vs ALLR (21.5M). ALLR has higher revenues than CYPH: ALLR (345K) vs CYPH (0).
ALLRCYPHALLR / CYPH
Capitalization21.6M77M28%
EBITDA-10.89M-56.75M19%
Gain YTD25.926-37.672-69%
P/E Ratio0.1217.071%
Revenue345K0-
Total Cash19.8M6.69M296%
Total Debt21.5M38K56,579%
FUNDAMENTALS RATINGS
CYPH: Fundamental Ratings
CYPH
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
14
SEASONALITY SCORE
1..100
7

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLRCYPH
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
N/A
Bullish Trend 26 days ago
88%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ALLR
Daily Signal:
Gain/Loss:
CYPH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALAB439.6622.59
+5.42%
Astera Labs
UAN110.01-1.39
-1.25%
CVR Partners LP
LVLU7.31-0.27
-3.56%
Lulu's Fashion Lounge Holdings Inc
OMAB109.74-4.26
-3.74%
Grupo Aeroportuario del Centro Norte S.A.B. de C.V. ADS
VLN2.20-0.24
-9.84%
Valens Semiconductor Ltd

ALLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLR has been closely correlated with TAOX. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if ALLR jumps, then TAOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLR
1D Price
Change %
ALLR100%
-4.90%
TAOX - ALLR
87%
Closely correlated
-1.09%
NCNA - ALLR
86%
Closely correlated
-4.45%
NRXP - ALLR
81%
Closely correlated
-1.76%
ACRV - ALLR
48%
Loosely correlated
+1.59%
CRBU - ALLR
36%
Loosely correlated
+0.18%
More

CYPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYPH has been loosely correlated with INKT. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CYPH jumps, then INKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYPH
1D Price
Change %
CYPH100%
-2.19%
INKT - CYPH
42%
Loosely correlated
+0.54%
AXON - CYPH
40%
Loosely correlated
-3.16%
SABS - CYPH
36%
Loosely correlated
-1.50%
AMRN - CYPH
35%
Loosely correlated
-1.15%
ALLR - CYPH
30%
Poorly correlated
-4.90%
More